“Metabolic Reprogramming of Leukemia Stem Cells as a Novel Therapeutic Target for Relapsed Acute Myeloid Leukemia” (2026) Pakistan Journal of Medical & Cardiological Review, 5(1), pp. 5786–5812. doi:10.5281/zenodo.22067075.